Plasma membrane abundance dictates phagocytic capacity and functional crosstalk in myeloid cells.


Journal

bioRxiv : the preprint server for biology
Titre abrégé: bioRxiv
Pays: United States
ID NLM: 101680187

Informations de publication

Date de publication:
13 Sep 2023
Historique:
pubmed: 25 9 2023
medline: 25 9 2023
entrez: 25 9 2023
Statut: epublish

Résumé

Professional phagocytes like neutrophils and macrophages tightly control what they eat, how much they eat, and when they move after eating. We show that plasma membrane abundance is a key arbiter of these cellular behaviors. Neutrophils and macrophages lacking the G-protein subunit Gb4 exhibit profound plasma membrane expansion due to enhanced production of sphingolipids. This increased membrane allocation dramatically enhances phagocytosis of bacteria, fungus, apoptotic corpses, and cancer cells. Gb4 deficient neutrophils are also defective in the normal inhibition of migration following cargo uptake. In Gb4 knockout mice, myeloid cells exhibit enhanced phagocytosis of inhaled fungal conidia in the lung but also increased trafficking of engulfed pathogens to other organs. These results reveal an unexpected, biophysical control mechanism lying at the heart of myeloid functional decision-making.

Identifiants

pubmed: 37745515
doi: 10.1101/2023.09.12.556572
pmc: PMC10515848
pii:
doi:

Types de publication

Preprint

Langues

eng

Subventions

Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI087644
Pays : United States
Organisme : NIGMS NIH HHS
ID : R35 GM118167
Pays : United States

Auteurs

Benjamin Y Winer (BY)

Immunology Program, Memorial Sloan Kettering Cancer Center; New York, NY, USA.
Department of Microbiology and Immunology, University of California San Francisco; San Francisco, CA, USA.
Cardiovascular Research Institute, University of California San Francisco; San Francisco, CA, USA.
Department of Biochemistry and Biophysics, University of California San Francisco; San Francisco, CA, USA.

Alexander H Settle (AH)

Immunology Program, Memorial Sloan Kettering Cancer Center; New York, NY, USA.

Alexandrina M Yakimov (AM)

Immunology Program, Memorial Sloan Kettering Cancer Center; New York, NY, USA.

Carlos Jeronimo (C)

Immunology Program, Memorial Sloan Kettering Cancer Center; New York, NY, USA.

Tomi Lazarov (T)

Immunology Program, Memorial Sloan Kettering Cancer Center; New York, NY, USA.

Murray Tipping (M)

Immunology Program, Memorial Sloan Kettering Cancer Center; New York, NY, USA.

Michelle Saoi (M)

Immunology Program, Memorial Sloan Kettering Cancer Center; New York, NY, USA.

Anjelique Sawh (A)

New York Structural Biology Center; New York, NY, USA.

Anna-Liisa L Sepp (AL)

Department of Biomedical Engineering, Columbia University; New York, NY, USA.

Michael Galiano (M)

Immunology Program, Memorial Sloan Kettering Cancer Center; New York, NY, USA.

Yung Yu Wong (YY)

Immunology Program, Memorial Sloan Kettering Cancer Center; New York, NY, USA.

Justin S A Perry (JSA)

Immunology Program, Memorial Sloan Kettering Cancer Center; New York, NY, USA.

Frederic Geissmann (F)

Immunology Program, Memorial Sloan Kettering Cancer Center; New York, NY, USA.

Justin Cross (J)

Immunology Program, Memorial Sloan Kettering Cancer Center; New York, NY, USA.

Ting Zhou (T)

Immunology Program, Memorial Sloan Kettering Cancer Center; New York, NY, USA.

Lance C Kam (LC)

Department of Biomedical Engineering, Columbia University; New York, NY, USA.

Hilda Amalia Pasoli (HA)

Electron Microscopy Resource Center, The Rockefeller University; New York, NY, USA.

Tobias Hohl (T)

Immunology Program, Memorial Sloan Kettering Cancer Center; New York, NY, USA.

Jason G Cyster (JG)

Department of Microbiology and Immunology, University of California San Francisco; San Francisco, CA, USA.
Howard Hughes Medical Institute; Chevy Chase, MD, USA.

Orion D Weiner (OD)

Cardiovascular Research Institute, University of California San Francisco; San Francisco, CA, USA.
Department of Biochemistry and Biophysics, University of California San Francisco; San Francisco, CA, USA.

Morgan Huse (M)

Immunology Program, Memorial Sloan Kettering Cancer Center; New York, NY, USA.

Classifications MeSH